PTC Therapeutics Inc
NASDAQ:PTCT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
PTC Therapeutics Inc
NASDAQ:PTCT
|
US |
|
M
|
Manulife Financial Corp
SWB:MLU
|
CA |
|
I
|
International Games System Co Ltd
TPEX:3293
|
TW |
|
N
|
Northrop Grumman Corp
LSE:0K92
|
US |
|
M
|
Marchex Inc
F:NHM
|
US |
|
Remgro Ltd
OTC:RMGOF
|
ZA |
|
E
|
Eli Lilly and Co
BMV:LLY
|
US |
|
L
|
Loblaw Companies Ltd
OTC:LBLCF
|
CA |
|
S
|
Southern Copper Corp
F:PCU
|
US |
|
CME Group Inc
NASDAQ:CME
|
US |
|
L
|
Lloyds Banking Group PLC
F:LLD2
|
UK |
|
U
|
United Utilities Group PLC
OTC:UUGWF
|
UK |
|
GSK plc
F:GS70
|
UK |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PTCT's stock price target?
Price Target
106.08
USD
According to Wall Street analysts, the average 1-year price target for
PTCT is 106.08 USD with a low forecast of 70.7 USD and a high forecast of 136.5 USD.